Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

Teva's Phase IIb chronic migraine trial of TEV-48125 meets primary and secondary endpoints By PBR Staff Writer
Israel-based Teva Pharmaceutical Industries has reported positive results from a Phase IIb trial of two doses of subcutaneous TEV-48125, an investigational anti-calcitonin gene-related peptide (CGRP) monoclonal antibody for the prevention of chronic migraine.
Contract Research & Services > Contract Research > News
NGM, Merck collaborate to develop biologic therapies for various diseases By PBR Staff Writer
NGM Biopharmaceuticals and Merck have collaborated to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas.
Contract Research & Services > Contract Research > News Rigel, Bristol-Myers Squibb partner to develop cancer immunotherapies By PBR Staff Writer
Rigel Pharmaceuticals and Bristol-Myers Squibb have partnered for the discovery, development and commercialization of cancer immunotherapies.
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
Atlant Clinical Services
We provide a comprehensive range of services in clinical trials:
Contract Research & Services > Contract Research > Products
NGM, Merck collaborate to develop biologic therapies for various diseases
By PBR Staff Writer
NGM Biopharmaceuticals and Merck have collaborated to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas.
Contract Research & Services > Contract Research > News
Rigel, Bristol-Myers Squibb partner to develop cancer immunotherapies
By PBR Staff Writer
Rigel Pharmaceuticals and Bristol-Myers Squibb have partnered for the discovery, development and commercialization of cancer immunotherapies.
Contract Research & Services > Contract Research > News
Cyclenium and Fundación MEDINA partner to discover anti-infective drug candidates
By PBR Staff Writer
Cyclenium Pharma and Fundación Fundación Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía (MEDINA) have reached a drug discovery and collaboration agreement to develop new anti-infective drug candidates.
Contract Research & Services > Contract Research > News
MediVector completes enrollment in two Phase III trials of favipiravir to treat influenza
By PBR Staff Writer
US-based drug development firm MediVector has completed enrollment in two Phase III FAVOR trials of favipiravir, an orally administered novel anti-viral compound, in adults with uncomplicated influenza (flu).
Contract Research & Services > Contract Research > News
VistaGen, NIMH partner for Phase II trial of AV-101 to treat major depressive disorder
By PBR Staff Writer
US-based biopharmaceutical firm VistaGen Therapeutics has entered into a cooperative research and development agreement (CRADA) with the US National Institute of Mental Health (NIMH) for a Phase II trial of Orally-Active AV-101 to treat major depressive disorder (MDD).
Contract Research & Services > Contract Research > News
Galapagos releases positive Phase I trial results of GLPG1690
By PBR Staff Writer
Galapagos, a Belgium-based biotech firm, has reported positive results from its randomized, double-blind, placebo-controlled, single centre Phase I trial of its first-in-class molecule, GLPG1690, to treat patients with pulmonary disease.
Contract Research & Services > Contract Research > News
FeF Chemicals A/S to Change to Novo Nordisk Pharmatech A/S and makes the Transfer to SAP
Fef Chemicals A/S has confirmed that it will change its name to Novo Nordisk Pharmatech A/S as of September 1st 2015.
Contract Research & Services > Contract Research > Press Releases
Novo Nordisk, Karolinska Institutet partner for diabetes research program
By PBR Staff Writer
Danish pharmaceutical firm Novo Nordisk has signed a collaboration agreement with Sweden-based medical university Karolinska Institutet for diabetes research.
Contract Research & Services > Contract Research > News
View all Contract Research news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250